Roche expands hepatitis diagnostics portfolio
Almost 300 million people globally have chronic hepatitis B
Almost 300 million people globally have chronic hepatitis B
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
Subscribe To Our Newsletter & Stay Updated